Cargando…
P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Lippincott Williams & Wilkins
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429195/ http://dx.doi.org/10.1097/01.HS9.0000848308.86014.40 |
| _version_ | 1784779362505064448 |
|---|---|
| author | Perrone, S. Ortu La Barbera, E. Capria, S. Marchesi, F. Trisolini, S. M. Sorella, S. Antonacci, M. Minotti, C. Filipponi, V. Shafii Bafti, M. Equitani, F. Scerpa, M. C. Martelli, M. Cimino, G. |
| author_facet | Perrone, S. Ortu La Barbera, E. Capria, S. Marchesi, F. Trisolini, S. M. Sorella, S. Antonacci, M. Minotti, C. Filipponi, V. Shafii Bafti, M. Equitani, F. Scerpa, M. C. Martelli, M. Cimino, G. |
| author_sort | Perrone, S. |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-9429195 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2022 |
| publisher | Lippincott Williams & Wilkins |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-94291952022-08-31 P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML Perrone, S. Ortu La Barbera, E. Capria, S. Marchesi, F. Trisolini, S. M. Sorella, S. Antonacci, M. Minotti, C. Filipponi, V. Shafii Bafti, M. Equitani, F. Scerpa, M. C. Martelli, M. Cimino, G. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9429195/ http://dx.doi.org/10.1097/01.HS9.0000848308.86014.40 Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially. |
| spellingShingle | Posters Perrone, S. Ortu La Barbera, E. Capria, S. Marchesi, F. Trisolini, S. M. Sorella, S. Antonacci, M. Minotti, C. Filipponi, V. Shafii Bafti, M. Equitani, F. Scerpa, M. C. Martelli, M. Cimino, G. P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML |
| title | P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML |
| title_full | P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML |
| title_fullStr | P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML |
| title_full_unstemmed | P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML |
| title_short | P1362: FEASIBILITY OF HAEMATOPOIETIC STEM CELL MOBILIZATION AFTER CONSOLIDATION WITH GEMTUZUMAB OZOGAMICIN AND INTERMEDIATE-DOSES ARA-C AND DAUNORUBICIN IN AML |
| title_sort | p1362: feasibility of haematopoietic stem cell mobilization after consolidation with gemtuzumab ozogamicin and intermediate-doses ara-c and daunorubicin in aml |
| topic | Posters |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9429195/ http://dx.doi.org/10.1097/01.HS9.0000848308.86014.40 |
| work_keys_str_mv | AT perrones p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT ortulabarberae p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT caprias p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT marchesif p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT trisolinism p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT sorellas p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT antonaccim p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT minottic p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT filipponiv p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT shafiibaftim p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT equitanif p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT scerpamc p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT martellim p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml AT ciminog p1362feasibilityofhaematopoieticstemcellmobilizationafterconsolidationwithgemtuzumabozogamicinandintermediatedosesaracanddaunorubicininaml |